Egli-Spichtig, Daniela

Fibroblast growth factor 23 leads to endolysosomal routing of the renal phosphate cotransporters NaPi-IIa and NaPi-IIc in vivo

Küng, C. J., Haykir, B., Schnitzbauer, U., Egli-Spichtig, D., Hernando, N., & Wagner, C. A. (2021) · American Journal of Physiology-Renal Physiology

Parathyroid Disorders and TreatmentsIon Transport and Channel Regulation

Cited by 38

Controlled dietary phosphate loading in healthy young men elevates plasma phosphate and FGF23 levels

Gerber, J. S., Arroyo, E. M. P., Pastor, J., Correia, M., Rudloff, S., Moe, O. W., Egli-Spichtig, D., Mohebbi, N., & Wagner, C. A. (2025) · Pflügers Archiv - European Journal of Physiology

Parathyroid Disorders and TreatmentsBone health and osteoporosis research

Cited by 15

Intact FGF23 predicts serum phosphate improvement after combined nicotinamide and phosphate binder treatment in hemodialysis patients

Egli-Spichtig, D., Hamid, A. K., Arroyo, E. M. P., Ketteler, M., Wiecek, A., Rosenkranz, A. R., Pasch, A., Lorenz, H., Hellmann, B., Karus, M., et al. (2023) · Clinical Kidney Journal

Parathyroid Disorders and TreatmentsDialysis and Renal Disease Management

Cited by 9

Renal Dnase1 expression is regulated by FGF23 but loss of Dnase1 does not alter renal phosphate handling

Egli-Spichtig, D., Zhang, M. Y. H., Li, A., Pastor Arroyo, E. M., Hernando, N., Wagner, C. A., Chang, W., & Perwad, F. (2021) · Scientific Reports

Parathyroid Disorders and TreatmentsAlkaline Phosphatase Research Studies

Cited by 1